Prana to Present at the B. Riley FBR China Healthcare Investment & Partnering Symposium in Hangzhou, China
Dr. David Stamler will be presenting at the China Healthcare Investment & Partnering Symposium on Saturday 17 March 2018 at 9.30am China Standard Time.
PBT434 poster presented at the 6th International Multiple System Atrophy Conference
Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration
Dr David Stamler Biotech Showcase Presentation
Prana meeting with investors at world’s largest healthcare conference in San Francisco
Dr. David Stamler presenting at Biotech Showcase
Prana receives $3 million R&D Tax Incentive Refund
Prana has today announced that is has received a A$3.02 million cash refund under the Australian Government’s R&D Tax Incentive Scheme.
Annual General Meeting Presentation 2017
Prana AGM Investor Conference Call
Prana Biotechnology invites investors unable to attend the Annual General Meeting to participate via teleconference.
Annual Report Filed on Form 20-F with SEC
Prana has announced that it has filed its Annual Report on Form 20-F
Prana commences research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology
PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture